Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuichi Ando

Showing results (51-60 of 241) with videos related to

Pageof 25
Sort By:
International Journal of Clinical Oncology|November 19, 2004
Acute gefitinib-induced pneumonitisFumiyoshi Ohyanagi, Yuichi Ando, Fumio Nagashima, et al.
Social Science & Medicine (1982)|May 19, 2012
Community-level socioeconomic status and parental smoking in JapanKenji Takeuchi, Jun Aida, Manabu Morita, et al.
Community Dentistry and Oral Epidemiology|November 28, 2002
Longitudinal study on periodontal conditions in healthy elderly people in JapanToshinobu Hirotomi, Akihiro Yoshihara, Masatoshi Yano, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 3, 2014
Some questions on the randomized controlled trial of communication skills training for oncologistsBishal Gyawali, Hiroaki Tsukuura, Kazunori Honda, et al.
Anticancer Research|September 4, 2020
Phase I Study of LFA102 in Patients With Advanced Breast Cancer or Castration-resistant Prostate CancerHironobu Minami, Yuichi Ando, Kenji Tamura, et al.
Cancer Science|January 31, 2025
Genomic profiles of patients with skin melanoma in the era of immune checkpoint inhibitorsYao Liang, Osamu Maeda, Kazuki Nishida, et al.
Plos One|July 22, 2024
Effects of KRAS, STK11, KEAP1, and TP53 mutations on the clinical outcomes of immune checkpoint inhibitors among patients with lung adenocarcinomaYao Liang, Osamu Maeda, Chiaki Kondo, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|May 6, 2003
Pharmacogenomics of ABC transporters and its role in cancer chemotherapyAlex Sparreboom, Romano Danesi, Yuichi Ando, et al.
Cancer Chemotherapy and Pharmacology|September 4, 2010
The small-molecule tyrosine kinase inhibitor nilotinib is a potent noncompetitive inhibitor of the SN-38 glucuronidation by human UGT1A1Ken-ichi Fujita, Minako Sugiyama, Yuko Akiyama, et al.
Molecular and Clinical Oncology|July 11, 2019
Alterations in gene expression and DNA methylation profiles in gastric cancer cells obtained from ascitic fluids collected before and after chemotherapyOsamu Maeda, Ayumu Matsuoka, Kazuhiro Furukawa, et al.
Pageof 25

Showing results (51-60 of 241) with videos related to

Sort By:
Pageof 25
International Journal of Clinical Oncology|November 19, 2004
Acute gefitinib-induced pneumonitisFumiyoshi Ohyanagi, Yuichi Ando, Fumio Nagashima, et al.
Social Science & Medicine (1982)|May 19, 2012
Community-level socioeconomic status and parental smoking in JapanKenji Takeuchi, Jun Aida, Manabu Morita, et al.
Community Dentistry and Oral Epidemiology|November 28, 2002
Longitudinal study on periodontal conditions in healthy elderly people in JapanToshinobu Hirotomi, Akihiro Yoshihara, Masatoshi Yano, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 3, 2014
Some questions on the randomized controlled trial of communication skills training for oncologistsBishal Gyawali, Hiroaki Tsukuura, Kazunori Honda, et al.
Anticancer Research|September 4, 2020
Phase I Study of LFA102 in Patients With Advanced Breast Cancer or Castration-resistant Prostate CancerHironobu Minami, Yuichi Ando, Kenji Tamura, et al.
Cancer Science|January 31, 2025
Genomic profiles of patients with skin melanoma in the era of immune checkpoint inhibitorsYao Liang, Osamu Maeda, Kazuki Nishida, et al.
Plos One|July 22, 2024
Effects of KRAS, STK11, KEAP1, and TP53 mutations on the clinical outcomes of immune checkpoint inhibitors among patients with lung adenocarcinomaYao Liang, Osamu Maeda, Chiaki Kondo, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|May 6, 2003
Pharmacogenomics of ABC transporters and its role in cancer chemotherapyAlex Sparreboom, Romano Danesi, Yuichi Ando, et al.
Cancer Chemotherapy and Pharmacology|September 4, 2010
The small-molecule tyrosine kinase inhibitor nilotinib is a potent noncompetitive inhibitor of the SN-38 glucuronidation by human UGT1A1Ken-ichi Fujita, Minako Sugiyama, Yuko Akiyama, et al.
Molecular and Clinical Oncology|July 11, 2019
Alterations in gene expression and DNA methylation profiles in gastric cancer cells obtained from ascitic fluids collected before and after chemotherapyOsamu Maeda, Ayumu Matsuoka, Kazuhiro Furukawa, et al.
Pageof 25